Episodes
-
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH Recorded on October 29, 2024 Kerry A. Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, OH Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today!
-
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT Recorded on July 2, 2024 Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more! Jennifer R. Rushton, MD Clinical Pathology Associates Medical Director, Pathology and Laboratory Medicine Baptist Health System San Antonio, TX Eric Severson, MD, PhD Executive Director Medical Affairs and Evidence Generation Labcorp Oncology Shelton, CT This episode is supported by Labcorp Oncology.
-
Episodes manquant?
-
Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on September 20, 2024 Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare! Stacie B. Dusetzina, PhD Professor, Health Policy Ingram Professor of Cancer Research Vanderbilt University Medical Center Nashville, TN Bethany Lilly, JD Executive Director, Public Policy The Leukemia & Lymphoma Society Rye Brook, NY Resources mentioned in this episode:
-
Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA Recorded on June 27, 2024 Alex F. Herrera, MD Associate Professor Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation Associate Medical Director, Briskin Center for Clinical Research & City of Hope Duarte Clinical Trials Office City of Hope Medical Center Duarte, CA In this episode, Dr. Alex Herrera from City of Hope explores the intricacies of Hodgkin lymphoma, from diagnosis and monitoring techniques to treatment goals and options. He discusses emerging therapies, including the significance of clinical trials, strategies for managing side effects, long-term effects of treatment, and resources for healthcare professionals, patients, and families. Tune in to learn more today!
-
Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA Recorded on September 9, 2024 Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Shira Dinner, from Northwestern University, and Dr. Tom Martin, from University of California San Francisco, about their insights and key takeaways from the conference. Learn more by tuning in here! Shira Dinner, MD Associate Professor Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, IL Tom Martin, MD Clinical Professor of Medicine, Division of Hematology/Oncology Director, Clinical Research, Hematologic Malignancies Program Co-Leader, Cancer Immunology and Immunotherapy Associate Director, Myeloma Program University of California San Francisco San Francisco, CA
-
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA Recorded on June 6, 2024 Krish Patel, MD Director, Lymphoma Program Director, Hematologic Malignancies and Cellular Therapy Swedish Cancer Institute Seattle, WA Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on mantle cell lymphoma today!
-
Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA Recorded on June 4, 2024 Ximena Jordan-Bruno, MD Assistant Professor, Division of Hematology/Oncology University of Pennsylvania Philadelphia, PA Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition syndromes. Learn about key clinical features, diagnostic approaches, the role of genetic counseling, and future research directions. Tune in today for valuable updates to enhance your understanding and practice!
-
Susan Hong, MD, Virginia Commonwealth University, Richmond, VA Recorded on May 21, 2024 Susan Hong, MD Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center Associate Professor, School of Medicine Internal Medicine Virginia Commonwealth University Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University’s Massey Cancer Center, discusses survivorship care in adults. She explores the intersection of healthcare professional and patient goals in survivorship care, as well as disparities and challenges impacting access and follow-up. Dr. Hong offers strategies to improve adherence to survivorship care and communication between survivors and primary care practitioners. She also shares educational resources for healthcare professionals, patients, and caregivers to support effective survivorship care. Listen to this informative episode today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
-
David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA Recorded on April 25, 2024 David Dean, DDS, MSD, DABOM, FDS RCSEd Director, Oral Medicine Fred Hutchinson Cancer Center Clinical Associate Professor University of Washington School of Dentistry Seattle, WA Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that arise from treatment, and insights into preventative care. Dr. Dean also addresses special considerations for patients with cancer needing dental care and strategies for healthcare providers to provide optimal support for patients navigating dental challenges. Tune in to learn more today!
-
Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY Recorded on April 16, 2024 Cesar Rodriguez, MD Associate Professor of Medicine, Tisch Cancer Institute Clinical Director, Multiple Myeloma Center of Excellence Mount Sinai Hospital New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider’s role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of language and cultural considerations, along with the importance of caregiver support for older adult survivors. Listen in today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
-
Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA Recorded on April 4, 2024 Karen E. Effinger, MD, MS Associate Professor of Pediatrics Emory University School of Medicine Co-Director, Survivor Program Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta Atlanta, GA In this episode, Dr. Karen Effinger from Children’s Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
-
Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX Recorded on March 28, 2024 Hagop M. Kantarjian, M.D. Professor and Chairman, Department of Leukemia Samsung Distinguished University Chair in Cancer Medicine MD Anderson Cancer Center, University of Texas Houston, TX Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!
-
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO Recorded on March 12, 2024 Michael Tees, MD, MPH Director, Lymphoma Program Lymphoma Executive Committee Member, Sarah Cannon Research Institute Associate Member, Colorado Blood Cancer Institute Denver, CO Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more! This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.
-
Alfred Lee, MD, PhD, Yale University, New Haven, CT Recorded on February 22, 2024 Alfred Lee, MD, PhD Professor of Medicine, Yale School of Medicine Program Director, Hematology and Medical Oncology Fellowship Chief, Division of Classical Hematology, Yale Cancer Center Yale University New Haven, CT Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today!
-
Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL Recorded on December 7, 2023 Meghna Ailawadhi, M.B.B.S., M.D. Cancer Survivorship Consultant, Assistant Professor of Medicine Department of Hematology/Oncology Mayo Clinic Jacksonville, FL In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care, including strategies to support adherence. She also provides an overview of disparities and challenges in survivorship care, as well as education and support resources for healthcare professionals and survivors. Learn more by listening today! This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.
-
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2023 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical trials in leukemia, lymphoma, myeloma, MDS, and MPNs. Tune in to this informative update today!
-
Jeffery Auletta, MD, National Marrow Donor Program® (NMDP)/Be the Match® Recorded on November 30, 2023 Join us as Dr. Jeffery Auletta from the National Marrow Donor Program® (NMDP)/Be the Match® reflects on the history, advances, and future of transplantation to treat blood cancers. Dr. Auletta also shares insights on disparities and barriers to receiving a transplant, expanding access, and how healthcare professionals can support patients through transplantation. Tune in to this engaging episode today!
-
Jacqueline Barrientos, MD, MS, Laura Ortiz-Ravick, MA, Kristina Lopez, LCSW Recorded on November 3, 2023 Join us for this special episode, recorded live from the Florida Society of Clinical Oncology Annual Disparities in Cancer Care Summit. Guest host, Kristina Lopez, LCSW and Information Specialist at The Leukemia & Lymphoma Society, speaks with Dr. Jacqueline Barrientos from Mount Sinai Medical Center, and Laura Ortiz-Ravick, Director of Outreach and Health Promotion at The Leukemia & Lymphoma Society about barriers and disparities within the Hispanic and Latinx communities when navigating the cancer journey. Learn more by tuning in here!
-
Frank Penedo, Ph.D, University of Miami, Miami, FL Recorded on August 10, 2023 Tune in as we’re joined by Dr. Frank Penedo from the University of Miami for an important discussion on considerations in survivorship care of older adults. Dr. Penedo outlines long-term and late effects of treatment, including psychosocial implications, and the impact of culture and language on survivorship. He also shares strategies for follow-up care coordination, as well as communicating with survivors and their families. Be part of the conversation today! This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.
-
John Salsman, Ph.D, Wake Forest University School of Medicine, Winston-Salem, NC Recorded on June 22, 2023 In this episode, Dr. John Salsman from Wake Forest University School of Medicine joins special staff correspondent, Elissa Baldwin, to discuss quality of life in the cancer experience of adolescents and young adults (AYAs), including unique issues that AYAs face. Dr. Salsman offers approaches to questions healthcare providers can ask when communicating with AYAs and clinical resources for physicians and survivors. Tune in today!
- Montre plus
